Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants
A repeated cross-sectional study sponsored by Sanofi Pasteur to determine respiratory syncytial virus immunization rates in German infants. …
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports the completion of safety and immunogenicity testing for an RSV vaccine candidate delivered in a li…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Streptococcus Pneumoniae (Spn)
This trial analyzes upper respiratory tract immune responses in older adults who are infected or colonized with Streptococcus pneumoniae, to…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection
This clinical trial update reports on the duration of protection provided by nirsevimab against hospitalization due to respiratory syncytial…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants [Phase 3]
Phase 3 study of the Ad26.RSV.preF-based vaccine for prevention of RSV-mediated lower respiratory tract disease in Japanese participants has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: RSV Antibiotic Drivers And Resource-use
A completed clinical trial evaluating factors driving antibiotic use and resource utilization in Respiratory Syncytial Virus infections, con…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults [Phase 1]
This entry describes a Phase 1 study evaluating the safety and immunogenicity of revaccination with SCB-1019T in healthy adults for respirat…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans® [Phase 1]
A Phase 1 study evaluating ProTrans for treating respiratory complications associated with COVID-19, influenza A, human metapneumovirus, and…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo. [Phase 4]
This Phase 4 clinical trial in South Africa evaluates maternal safety and infant protection against RSV lower respiratory tract infection wh…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization [Phase 3]
Phase 3 trial assessing the safety and efficacy of an RSV F protein vaccine administered to pregnant individuals to protect newborns from re…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: A Study to Investigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric Participants
A completed clinical study sponsored by Shionogi examining how respiratory syncytial virus infection develops and changes over time in pedia…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: A Study of AK0529 in Adults Patients Hospitalized With RSV Infection [Phase 2]
A Phase 2 clinical trial evaluating AK0529 in adults hospitalized with respiratory syncytial virus infection has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life [Phase 3]
This Phase 3 trial evaluated a single intramuscular dose of nirsevimab to prevent hospitalizations due to respiratory syncytial virus in hea…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults [Phase 3]
A Phase 3 study evaluating the safety and immune response of an investigational RSV OA vaccine in combination with a herpes zoster vaccine i…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Transplacental Transmission of RSV (TTRSV)
The Tulane University-sponsored trial NCT05443607 investigates transplacental transmission of RSV (TTRSV). It covers conditions including SA…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults [Phase 2]
Phase 2 study of the RSV/Flu-01E vaccine in older adults has completed, sponsored by the Research Institute of Influenza in Russia.
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay
Clinical performance evaluation of the NeuMoDx FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 assay completed, assessing detection of…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults [Phase 1]
Phase 1 safety and immunogenicity trial update for LYB005 RSV vaccine in healthy adults; trial status is ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age.
An ongoing clinical trial is evaluating whether Nirsevimab reduces hospitalizations due to RSV infection in infants under one year; the stud…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age [Phase 1]
Phase 1 trial assessing safety and immune response of Pfizer's RSVpreF vaccine in children aged 2 to under 18; study completed with results …
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Emission Patterns of Respiratory Syncytial Virus
Sponsored by Wake Forest University Health Sciences, the trial investigated emission patterns of the Respiratory Syncytial Virus (RSV). The …
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Respiratory Syncytial Virus Infection in Exacerbations of Chronic Obstructive Pulmonary Diasease: the RECODE Study
A clinical trial (RECODE) evaluating respiratory syncytial virus infection in exacerbations of chronic obstructive pulmonary disease is curr…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults. [Phase 1]
Pfizer conducted a Phase 1 study in healthy Chinese adults to evaluate tolerability, safety, and pharmacokinetics of sisunatovir; the trial …
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and immunogenicity of three recombinant live-attenuated RSV vaccines in RSV-seronegative chil…
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Peginterferon α-2b Injection for the Treatment of Pediatric RSV Bronchiolitis [NA]
This document reports an ongoing clinical trial evaluating peginterferon alfa-2b injections for pediatric RSV-associated bronchiolitis; recr…